Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pumas-AI is a health technology company that specializes in providing advanced software solutions for pharmaceutical modeling and simulation. The company's flagship platform, Pumas (Pharmaceutical Modeling and Simulation), is built on the Julia programming language and integrates traditional pharmacometrics with modern machine learning through its DeepPumas extension. Pumas-AI offers tools for non-linear mixed-effects modeling (NLME), clinical trial simulation, and automated reporting, aiming to accelerate drug development and optimize dosing regimens. By combining scientific computing with deep learning, the company enables researchers to analyze complex longitudinal data and improve predictive accuracy in drug discovery and clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DeepPumas.